While COTL1 has alreadybeen proposed as a potential prognostic biomarker in glioma and breast cancer, Dimberg et al. showed that DCPS mRNA and protein expression weresignificantly up-regulated in patients with colorectal cancer. This evidence concerns the gene COTL1 and breast carcinoma.